Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Saved in:
| Title: | Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY. |
|---|---|
| Authors: | Balmaña J; Medical Oncology Department, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Delaloge S; Breast Cancer Unit, Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Labidi-Galy I; Department of Oncology, Geneva University Hospital, Department of Medicine, Division of Oncology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., O'Shaughnessy J; Baylor University Medical Center, Texas Oncology and US Oncology, Dallas, TX, USA., Park YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Eisen AF; Division of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., You B; Department of Medical Oncology, Hospices Civils of Lyon Cancer Institute, Centre for Therapeutic Investigation in Oncology and Haematology of Lyon, Lyon Sud Hospital Centre, Lyon, France.; Faculty of Medicine of Lyon Sud, Claude Bernard Lyon 1 University, Lyon, France.; GINECO-GINEGEPS, Paris, France., Bourgeois H; Medical Oncology Department, Victor Hugo Clinic-Jean Bernard Center, Le Mans, France., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.; Cancer Research Center of Marseille, Aix-Marseille University, French National Centre for Scientific Research, National Institute for Health and Medical Research, Marseille, France., Kemp Z; Breast Cancer Unit, The Royal Marsden NHS Foundation Trust, London, UK., Swampillai A; Department of Clinical Oncology, Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK.; Breast Cancer Now Research Unit, Guy's Hospital, King's College London, London, UK., Jankowski T; Department of Pneumology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland., Sohn JH; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Poddubskaya E; Surgical Department N2, Clinical Center VitaMed, Moscow, Russia., Mukhametshina G; Ministry of Health of the Republic of Tatarstan, Kazan, Russia., Aksoy S; Medical Oncology Department, Hacettepe University Cancer Institute, Ankara, Turkey., Timcheva CV; Medical Oncology Department, MHAT Nadezhda, Sofia, Bulgaria., Park-Simon TW; Frauenklinik, Hannover Medical School, Hannover, Germany., Antón-Torres A; Department of Medical Oncology, Miguel Servet University Hospital and Aragon Health Research Institute, Zaragoza, Spain., John E; Statistics, AstraZeneca, Cambridge, UK., Baria K; US Medical Affairs, AstraZeneca, Gaithersburg, MD, USA., Gibson I; Global Medical Affairs, AstraZeneca, Cambridge, UK., Gelmon KA; Department of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, Canada. kgelmon@bccancer.bc.ca. |
| Corporate Authors: | LUCY investigators |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Apr; Vol. 204 (2), pp. 237-248. Date of Electronic Publication: 2023 Dec 19. |
| Publication Type: | Clinical Trial, Phase III; Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-023-07165-x |
